Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Zeina Al-Kanaani"'
Autor:
Moza Alishaq, Andrew Jeremijenko, Zeina Al-Kanaani, Hanaa Nafady-Hego, Diana H Jboor, Rosaline Saba, Jameela Al-Ajmi, Nasser Asad Alansari, Anil George Thomas, Sameera Bihi Fareh, Suni Vinoy, Maryam Nooh, Nadya Alanzi, Abdul-Badi Abou-Samra, Adeel Ajwad Butt
Publikováno v:
PLoS ONE, Vol 16, Iss 9, p e0257845 (2021)
BackgroundWhile many studies have reported the rate and risk of SARS-CoV-2 infection among healthcare workers (HCWs), there are scant data regarding the impact of employment type and job grades upon such risk.MethodsWe determined the rate of SARS-CoV
Externí odkaz:
https://doaj.org/article/bbfac4720f2a49ceb458081caacd7e11
Autor:
Yousuf Al Masalmani, Ali Nizar Latif, Peter Coyle, Abdul-Badi Abou-Samra, Laith J. Abu Raddad, Adeel A. Butt, Hiam Chemaitelly, Anvar Hassan Kaleeckal, Abdullatif Al Khal, Zeina Al Kanaani, Hanaa Nafady-Hego, Roberto Bertollini
Publikováno v:
International Journal of Infectious Diseases, Vol 110, Iss, Pp 353-358 (2021)
International Journal of Infectious Diseases
International Journal of Infectious Diseases
Background: Breakthrough infections after SARS-CoV-2 vaccination have been reported. Clinical outcomes in these persons are not widely known. Methods: We evaluated all vaccinated persons with breakthrough infection ≥14 days after the second vaccine
Autor:
Anil George Thomas, Andrew Jeremijenko, Rosaline Saba, Suni Vinoy, Abdul-Badi Abou-Samra, Nadya Alanzi, Sameera Bihi Fareh, Diana H. Jboor, Maryam Nooh, Zeina Al-Kanaani, Jameela Al-Ajmi, Hanaa Nafady-Hego, Moza Alishaq, Adeel A. Butt, Nasser Al-Ansari
Publikováno v:
PLoS ONE
PLoS ONE, Vol 16, Iss 9, p e0257845 (2021)
PLoS ONE, Vol 16, Iss 9, p e0257845 (2021)
Background While many studies have reported the rate and risk of SARS-CoV-2 infection among healthcare workers (HCWs), there are scant data regarding the impact of employment type and job grades upon such risk. Methods We determined the rate of SARS-
Autor:
Adeel A. Butt, MBBS, MS, Hanaa Nafady-Hego, PhD, Hiam Chemaitelly, MS, Abdul-Badi Abou-Samra, MD, PhD, Abdullatif Al Khal, MD, Peter V. Coyle, MD, Zeina Al Kanaani, PhD, Anvar H. Kaleeckal, MS, Ali Nizar Latif, MD, Yousuf Al Masalmani, MD, Roberto Bertollini, MD, Laith J. Abu Raddad, PhD
Publikováno v:
International Journal of Infectious Diseases, Vol 110, Iss , Pp 353-358 (2021)
Background: Breakthrough infections after SARS-CoV-2 vaccination have been reported. Clinical outcomes in these persons are not widely known. Methods: We evaluated all vaccinated persons with breakthrough infection ≥14 days after the second vaccine
Externí odkaz:
https://doaj.org/article/146579adf7264831976a3be2f0c2c797